Dura_Pharmaceuticals,_Inc._v._Broudo
Dura Pharmaceuticals, Inc. v. Broudo
2005 United States Supreme Court case
Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005), is a securities fraud decision by the Supreme Court of the United States, holding that an inflated purchase price will not by itself constitute or proximately cause the relevant economic loss needed to allege and prove "loss causation."
This article needs additional citations for verification. (February 2010) |